3 days Exact Sciences Stock Rises After FDA Signs Off On New Cologuard Investor's Business Daily

Exact Sciences stock rose Friday after the FDA approved the company’s next-generation colon cancer detection test, Cologuard Plus.
The post Exact Sciences Stock Rises After FDA Signs Off On New Cologuard appeared first on Investor's Business Daily.